Zoledronate maintains bone loss after denosumab discontinuationAugust 28, 2019RheumatologyWomen's HealthEndocrinology
High-dose vitamin D for bone health may do more harm than goodAugust 27, 2019EndocrinologyRheumatologyGeriatricsWomen's Health
Analysis finds no mortality reductions with osteoporosis drugsAugust 19, 2019Preventive CareRheumatologyEndocrinology
NSAIDs a significant mediator of cardiovascular risk in osteoarthritisAugust 7, 2019CardiologyRheumatology
FDA finds increased blood clot, death risk associated with XeljanzJuly 26, 2019GastroenterologyRheumatology
FDA advisors recommend nintedanib for SSc interstitial lung diseaseJuly 26, 2019PulmonologyRheumatologyRare Diseases
